HCP-event, HCP-event 2024 First National Cancer Congress Malaysia 23 Jun View the webcast of this presentation at: https://www.lungcancer.net.my/hcp/1st-national-cancer-congress-malaysia-2024/ View Fullscreen View Fullscreen View Fullscreen lungadmin 1st National Cancer Congress Malaysia 2024 Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial